Counterfeit Avastin Found In US, Roche Says

Law360, New York (February 14, 2012, 7:17 PM EST) -- A unit of Swiss health care company Roche Holding AG and the U.S. Food and Drug Administration on Tuesday warned health care providers who had purchased medicines from a foreign supplier that a counterfeit product posing as blockbuster cancer drug Avastin had been found in the U.S.

Genentech Inc. announced that chemical tests of counterfeit vials conducted this month had confirmed that they did not contain bevacizumab, the active ingredient in Avastin, a drug approved by the FDA to treat four cancers, and therefore the counterfeits...
To view the full article, register now.